SRZN Archived Articles
Surrozen, Inc. (SRZN): Pioneering Targeted Therapeutics to Selectively Activate the Wnt Pathway
Published on March 13, 2025
Pioneering Targeted Therapeutics: The Remarkable Journey of Surrozen, Inc. (SRZN)
Published on November 30, 2024
Surrozen, Inc. (NASDAQ:SRZN): A Promising Biotech Poised for Breakthrough Therapies
Published on September 24, 2024